A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Clinical trial NCT04462770 · RECRUITING

Trial details

NCT number: NCT04462770
Sponsor: Epygenix
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Dravet Syndrome

Start date: 2020-09-15
Primary completion: 2027-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.